← Open Payments lookup

DAVID MOES: Open Payments

NPI 1336697754 · CALABASH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,624 in 79 payments from 13 companies in 2025. Trend: 2023 $1,020 · 2024 $1,619 · 2025 $1,624

Food & beverage: $1,585Education: $39
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.22$567
Otsuka America Pharmaceutical, Inc.15$248
Janssen Pharmaceuticals, Inc10$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$188
E.R. Squibb & Sons, L.L.C.6$106
ABBVIE INC.5$86
Teva Pharmaceuticals USA, Inc.3$50
Neurocrine BioSciences, Inc.2$43
Luye Pharma (USA) Ltd.2$36
Alkermes, Inc.2$36

Products named: HETLIOZ, INVEGA SUSTENNA, FANAPT, CAPLYTA, REXULTI, COBENFY, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across NC — which companies pay providers there.